Trials / Active Not Recruiting
Active Not RecruitingNCT05488483
A Study of Tumor Imaging With Multispectral Optoacoustic Tomography
A Feasibility Study of Multispectral Optoacoustic Tomography (MSOT) Imaging in Patients With Tumors
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Participants in this study will have Multispectral Optoacoustic Tomography/MSOT imaging of both breasts immediately before their ultrasound-guided breast biopsy procedure begins. After the MSO imaging is completed, participation in the study will end.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Multispectral Optoacoustic Tomography Imaging | Each participants will undergo MSOT imaging of the suspicious breast tumor detected with ultrasound imaging and any additional lesion present in either breast before undergoing ultrasound-guided breast biopsy as the standard of care. Melanoma participants with pathologically confirmed ITM will undergo MSOT imaging following physical exam and biopsy. Melanoma patients receiving immunotherapy will undergo MSOT imaging prior to and following immunotherapy. |
Timeline
- Start date
- 2022-07-27
- Primary completion
- 2026-07-27
- Completion
- 2026-07-27
- First posted
- 2022-08-04
- Last updated
- 2026-02-19
Locations
4 sites across 2 countries: United States, Germany
Source: ClinicalTrials.gov record NCT05488483. Inclusion in this directory is not an endorsement.